GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Shares Buyback Ratio %

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Shares Buyback Ratio % : -65.19 (As of Jun. 06, 2024)


View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. OWC Pharmaceutical Research's current shares buyback ratio was -65.19%.


OWC Pharmaceutical Research Shares Buyback Ratio % Historical Data

The historical data trend for OWC Pharmaceutical Research's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Shares Buyback Ratio % Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only -262.40 -3.87 -71.18 -5.96 -1.66

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -1.49 -17.17 -22.88 -13.05

OWC Pharmaceutical Research Shares Buyback Ratio % Calculation

OWC Pharmaceutical Research's Shares Buyback Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2017 ) - Shares Outstanding (EOP) (A: Dec. 2018 )) / Shares Outstanding (EOP) (A: Dec. 2017 )
=(147.759 - 150.207) / 147.759
=-1.66%

OWC Pharmaceutical Research's Shares Buyback Ratio for the quarter that ended in Sep. 2019 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2019 ) - Shares Outstanding (EOP) (A: Sep. 2019 )) / Shares Outstanding (EOP) (A: Jun. 2019 )
=(216.266 - 244.478) / 216.266
=-13.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OWC Pharmaceutical Research Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Traded in Other Exchanges
N/A
Address
2 Ben Gurion Street, Ramat Gan, ISR, 5257334
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.
Executives
Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines

From GuruFocus

OWC Pharmaceutical Research Corp, Letter to Shareholders

By PRNewswire PRNewswire 02-11-2019